Ascendis Pharma AS（ASND）— 同業公司組
數據截至2026-09-21 — 評分每個交易日晚間重新計算。分組標準＝首先為共同的Closelook指數成分，其次為產業。Closelook研究日記，不構成投資建議。
Ascendis Pharma AS的Closelook綜合評分為52/100，在同業公司組內排名第7位（共7家）——組內評分最高的是BB Biotech AG（74/100）。
| 名稱 | 綜合 | 動能 | 品質 | 估值 | 訊號 | 距52週高點 |
|---|---|---|---|---|---|---|
| ASND Ascendis Pharma AS | 52 | 55 | 63 | 27 | info | 15.8% |
| BION.SW BB Biotech AG | 74 | 70 | 96 | 80 | info | 9.1% |
| ARGX.BR Argen-X | 65 | 81 | 75 | 27 | ok | 6.2% |
| ARGX argenx NV ADR | 64 | 76 | 74 | 26 | ok | 7.9% |
| ONC BeiGene, Ltd. | 64 | 79 | 63 | 32 | ok | 5.1% |
| REGN Regeneron Pharmaceuticals Inc | 60 | 65 | 71 | 51 | bull | 8.7% |
| UCB.BR UCB SA | 60 | 17 | 70 | 58 | warn | 26.4% |
FAQ · from the current data · as of 2026-09-21
Quick answers
Ascendis Pharma AS在Closelook涵蓋範圍內的同業公司有哪些？
分組首先根據共同的Closelook指數成分，其次根據產業：BB Biotech AG (BION.SW)、Argen-X (ARGX.BR)、argenx NV ADR (ARGX)、BeiGene, Ltd. (ONC)、Regeneron Pharmaceuticals Inc (REGN)、UCB SA (UCB.BR)。
ASND相對同業公司的評分如何？
Ascendis Pharma AS的綜合評分為52/100，組內排名第7位（共7家），截至2026-09-21；組內最高綜合評分為BB Biotech AG（74/100）。Closelook評分為研究日記讀數，不構成評等或投資建議。
Related in the Closelook universe
then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- ONC BeiGene, Ltd.industry
- REGN Regeneron Pharmaceuticals Incindustry
- UCB.BR UCB SAindustry
- MRNA Moderna Incindustry
- TWST Twist Bioscience Corpindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- RXRX Recursion Pharmaceuticals Incindustry
- HALO Halozyme Therapeutics Incindustry
- SMMT Summit Therapeutics PLCindustry
- GMAB Genmab ASindustry
- CRSP Crispr Therapeutics AGindustry
- IBRX Immunitybio Incindustry
- SRPT Sarepta Therapeutics Incindustry
- TGTX TG Therapeutics Incindustry
- EXEL Exelixis Incindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- INCY Incyte Corporationindustry